Dr. Jasvinder Singh
Scientist, Hormel Institute, University of Minnesota, USA.
Dr. Singh’s research mainly focuses on studying the crosstalk between genetic and epigenetic factors that regulate tissue homeostasis and cancer pathogenesis. We integrate epigenomics and functional genomics studies to better understand how cancer arises and progresses, and to identify actionable targets for developing effective cancer prevention and therapeutics. We are currently pursuing these studies in breast cancer models. Breast cancer is the leading cause of death from cancer in women worldwide and over 42,000 women die from BC each year. Before joining the University of Minnesota Dr. Singh received his Ph.D in Cancer Biology from the CSIR-Indian Institute of Integrative Medicine in Jammu, India. His graduate studies focused on mechanistic studies on the anticancer role of bioactive compounds isolated from natural products via stimulating the immune system. He gained substantial training and experience in designing and implementing in vitro cell culture experiments and in vivo studies in mouse tumor models.